For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | Vaginal insert Placebo: Placebo vaginal insert | 0 | None | 0 | 4 | 3 | 4 | View |
| DARE-VVA1 1mg | vaginal insert Tamoxifen: Tamoxifen vaginal insert | 0 | None | 0 | 3 | 2 | 3 | View |
| DARE-VVA1 5mg | vaginal insert Tamoxifen: Tamoxifen vaginal insert | 0 | None | 0 | 4 | 4 | 4 | View |
| DARE-VVA1 10mg | vaginal insert Tamoxifen: Tamoxifen vaginal insert | 0 | None | 0 | 3 | 3 | 3 | View |
| DARE-VVA1 20mg | vaginal insert Tamoxifen: Tamoxifen vaginal insert | 0 | None | 0 | 3 | 3 | 3 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra (25.0) | View |
| Migraine | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra (25.0) | View |
| Sciatica | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra (25.0) | View |
| Hot flush | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDra (25.0) | View |
| Genital rash | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra (25.0) | View |
| Vulvovaginal discomfort | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra (25.0) | View |
| Vulvovaginal pruritis | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra (25.0) | View |
| Postmenopausal hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra (25.0) | View |
| Vulvovaginal erythema | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra (25.0) | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra (25.0) | View |